Epidemiology of Parkinson's disease
- PMID: 1584176
- PMCID: PMC7172502
- DOI: 10.1016/S0733-8619(18)30212-3
Epidemiology of Parkinson's disease
Abstract
Additional epidemiologic studies may provide important insights into the etiology of Parkinson's disease. Moreover as the elderly population of Europe and the United States grows, accurate public health planning requires accurate incidence and prevalence estimates. The recent development of a therapy that may slow disease progression (see article by Tetrud elsewhere in this issue) makes early identification and treatment of Parkinson's disease particularly important. Investigations of early markers of Parkinson's disease or markers of disease susceptibility are critical areas of future research, requiring careful collaboration between epidemiologists and laboratory scientists.
References
-
- Aquilonius S.M., Hartvig P. A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand. 1986;74:379–382. - PubMed
-
- Ashok P.P., Radhakrishan K., Sridharan R. Parkinsonism in Benghazi, East Libya. Clin Neurol Neurosurg. 1986;88:109–113. - PubMed
-
- Barbeau A., Pourcher E. New data on the genetics of Parkinson’s disease. Can J Neurol Sei. 1982;9:53–60. - PubMed
-
- Barbeau A., Roy M. Uneven prevalence of Parkinson’s disease in the province of Quebec. Can J Neurol Sei. 1985;12:169.
-
- Baumann R.J., Jameson H.D., McKean H.E. Cigarette smoking and Parkinson’s disease: I. A comparison of cases with matched neighbors. Neurology. 1980;30:839–843. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical